Pioneering diagnostics

bioMérieux Corporate Website | Pioneering diagnostics

bioMérieux acquires a majority stake in Hybiome    

Specialized in automated immunoassay tests, Hybiome develops, manufactures and markets a complete range of diagnostic solutions cleared by the China Food and Drug Administration. Thanks to this acquisition, we strengthen our presence both in China and in the immunoassay market.

Read more

Discover our clinical solutions

ENDOZYME® II GO  Innovation Awards 2018

Our  test for the detection of endotoxins in pharmaceutical microbiology control, ENDOZYME® II GO, has been shortlisted as one of the winners in the Medicine Maker Innovation Awards 2018. These awards recognize innovative technologies launched in 2018 to support pharma development and manufacturing.

Read more about ENDOZYME® II GO >> 

 

All our industry solutions

Best wishes

Watch the video